Christine Bellon - Feb 14, 2025 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Signature
By: /s/ Christine Bellon
Stock symbol
BEAM
Transactions as of
Feb 14, 2025
Transactions value $
-$267,800
Form type
4
Date filed
2/19/2025, 04:10 PM
Previous filing
Feb 3, 2025
Next filing
Apr 2, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $68.5K +9.49K +9.22% $7.22 112K Feb 14, 2025 Direct F1
transaction BEAM Common Stock Options Exercise $3.67K +508 +0.45% $7.22 113K Feb 14, 2025 Direct F1
transaction BEAM Common Stock Sale -$340K -10K -8.85% $34.00 103K Feb 14, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -9.49K -100% $0.00 0 Feb 14, 2025 Common Stock 9.49K $7.22 Direct F2
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -508 -4.65% $0.00 10.4K Feb 14, 2025 Common Stock 508 $7.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2024.
F2 The option vested as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested.
F3 The option vested as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested.